Reliability of Hammersmith Examination in Prediction of Neurological Outcomes (REHAPENO)
NCT ID: NCT03580252
Last Updated: 2019-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2018-03-01
2019-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
NCT05217186
NEO Rehab for Infants at Risk of Cerebral Palsy
NCT03372590
Cerebral Magnetic Resonance Spectroscopy at Term Corrected Age and Dysexecutive Syndrome in Very Preterm Children at 5.5-years-old
NCT06055062
Study of Generalized Movements for Early Prediction of Cerebral Palsy
NCT00749008
Cerebral Abnormalities Detected by MRI, Realized at the Age of Term and the Emergence of Executive Functions
NCT02083822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will be only single arm/single group. This group would receive the regular practice of MRI, Ultrasound (US) and Hammersmith assessments. The 3 assessments would be compared in relationships with the neonatal developmental outcomes (developmental milestones).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preterm Infant Neurological Follow-Up
Preterm infants \<37 weeks' gestational age (GA) at birth admitted to the neonatal nurseries at the Abha Private Hospital in Kingdom of Saudi Arabia. This project aims to recruit 50 infants \<37weeks at birth over a 1-year stating from march 2018.
A Correlation analyses for the outcomes with initial regular medical practice of MRI/Ultrasound and Hammersmith assessment.
Correlation analyses for the outcomes
No medical intervention would be done. The single arm would receive regular practice of Hammersmith Assessment and MRI / Ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Correlation analyses for the outcomes
No medical intervention would be done. The single arm would receive regular practice of Hammersmith Assessment and MRI / Ultrasound
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abha International Private Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed Fleifel, MD MSc PhD
Role: STUDY_CHAIR
College of Medicine, Mansoura University
Rawya Abdelghani, MD MSc PhD
Role: STUDY_DIRECTOR
College of Medicine, Al Azhar University
Mohamed Ameen, MICR RPh
Role: PRINCIPAL_INVESTIGATOR
IQVIA Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abha Private Hospital
Abhā, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fleifel001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.